162 related articles for article (PubMed ID: 16284376)
41. Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women.
Hernández-Hernández DM; Ornelas-Bernal L; Guido-Jiménez M; Apresa-Garcia T; Alvarado-Cabrero I; Salcedo-Vargas M; Mohar-Betancourt A; Garcia-Carranca A
Gynecol Oncol; 2003 Aug; 90(2):310-7. PubMed ID: 12893192
[TBL] [Abstract][Full Text] [Related]
42. Alcohol consumption and viral load are synergistically associated with CIN1.
Min KJ; Lee JK; Lee S; Kim MK
PLoS One; 2013; 8(8):e72142. PubMed ID: 23977233
[TBL] [Abstract][Full Text] [Related]
43. The DNA load of six high-risk human papillomavirus types and its association with cervical lesions.
Del Río-Ospina L; Soto-De León SC; Camargo M; Moreno-Pérez DA; Sánchez R; Pérez-Prados A; Patarroyo ME; Patarroyo MA
BMC Cancer; 2015 Mar; 15():100. PubMed ID: 25885207
[TBL] [Abstract][Full Text] [Related]
44. Human papillomavirus viral load in cervical intraepithelial neoplasia as a prognostic factor in a Mexican population.
Bencomo-Álvarez AE; Limones-Perches I; Suárez-Rincón AE; Ramírez-Jirano LJ; Borrayo-Carbajal E; Sánchez-Corona J; Montoya-Fuentes H
Genet Mol Res; 2012 Dec; 11(4):4720-7. PubMed ID: 23096904
[TBL] [Abstract][Full Text] [Related]
45. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
[TBL] [Abstract][Full Text] [Related]
46. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
[TBL] [Abstract][Full Text] [Related]
47. Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.
Monsonego J; Bohbot JM; Pollini G; Krawec C; Vincent C; Merignargues I; Haroun F; Sednaoui P; Monfort L; Dachez R; Syrjänen K
Gynecol Oncol; 2005 Oct; 99(1):160-8. PubMed ID: 16023184
[TBL] [Abstract][Full Text] [Related]
48. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
[TBL] [Abstract][Full Text] [Related]
49. Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia.
Harris TG; Kulasingam SL; Kiviat NB; Mao C; Agoff SN; Feng Q; Koutsky LA
Am J Epidemiol; 2004 May; 159(9):834-42. PubMed ID: 15105176
[TBL] [Abstract][Full Text] [Related]
50. High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients.
Nath R; Mant C; Luxton J; Hughes G; Raju KS; Shepherd P; Cason J
Arthritis Rheum; 2007 May; 57(4):619-25. PubMed ID: 17471531
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.
Arora R; Kumar A; Prusty BK; Kailash U; Batra S; Das BC
Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):104-9. PubMed ID: 15950365
[TBL] [Abstract][Full Text] [Related]
52. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP.
Mo LZ; Song HL; Wang JL; He Q; Qiu ZC; Li F
Asian Pac J Cancer Prev; 2015; 16(10):4297-302. PubMed ID: 26028089
[TBL] [Abstract][Full Text] [Related]
53. Type-specific distribution of HPV along the full spectrum of cervical carcinogenesis in Taiwan: an indication of viral oncogenic potential.
Ding DC; Hsu HC; Huang RL; Lai HC; Lin CY; Yu MH; Chu TY
Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):245-51. PubMed ID: 18502563
[TBL] [Abstract][Full Text] [Related]
54. Human papillomavirus DNA integration and messenger RNA transcription in cervical low- and high-risk squamous intraepithelial lesions in Austrian women.
Manavi M; Hudelist G; Fink-Retter A; Gschwantler-Kaulich D; Pischinger K; Czerwenka K
Int J Gynecol Cancer; 2008; 18(2):285-94. PubMed ID: 17587315
[TBL] [Abstract][Full Text] [Related]
55. High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or = 50 years of age.
Lin CT; Tseng CJ; Lai CH; Hsueh S; Huang HJ; Law KS
J Reprod Med; 2000 Apr; 45(4):345-50. PubMed ID: 10804494
[TBL] [Abstract][Full Text] [Related]
56. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
[No Abstract] [Full Text] [Related]
57. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
[No Abstract] [Full Text] [Related]
58. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
[TBL] [Abstract][Full Text] [Related]
59. [Usefulness of Hybrid Capture II detection of high-risk human papillomavirus in women with abnormal pap-smears of the uterine cervix].
Tena D; Garrido N; Menéndez JM; Delgado JJ; Romanyk J; González Mdel R; Zapico A; Beltrán M
Enferm Infecc Microbiol Clin; 2005 Oct; 23(8):474-8. PubMed ID: 16185561
[TBL] [Abstract][Full Text] [Related]
60. High level of correlation of human papillomavirus-16 DNA viral load estimates generated by three real-time PCR assays applied on genital specimens.
Fontaine J; Gravitt P; Duh LM; Lefevre J; Pourreaux K; Hankins C; Coutlée F
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2200-7. PubMed ID: 16172232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
